Management of adult patients with podocytopathies-an update from the ERA Immunonephrology Working Group
S Mirioglu, L Daniel-Fischer, I Berke… - Nephrology Dialysis …, 2024 - academic.oup.com
The histopathological lesions, minimal change disease (MCD) and focal segmental
glomerulosclerosis (FSGS), are entities without immune complex deposits which can cause …
glomerulosclerosis (FSGS), are entities without immune complex deposits which can cause …
[PDF][PDF] hmad, SH, Ba ema, IM, Bruchfeld,.,… Kronbichler,.(2024)
S Mirioglu, L Daniel-Fischer… - Management of adult … - scholarlypublications …
The histopathological lesions, minimal change disease (MCD) and focal segmental
glomerulosclerosis (FSGS) are entities without immune complex deposits which can cause …
glomerulosclerosis (FSGS) are entities without immune complex deposits which can cause …
Approach to diagnosis and management of primary glomerular diseases due to podocytopathies in adults: core curriculum 2020
W Ahn, AS Bomback - American journal of kidney diseases, 2020 - Elsevier
Podocyte injury is the initiating step in the pathway toward clinically evident forms of
nephrotic syndrome known as podocytopathies, represented as either minimal change …
nephrotic syndrome known as podocytopathies, represented as either minimal change …
Adult Primary Podocytopathy in Southeast Asia: Clinicopathological Characteristics, Treatment-Associated Toxicities, and Outcomes: PUB237
RS Lim, CC Gan, G Boh, SY Yew, SH Ooi… - Journal of the …, 2022 - journals.lww.com
Background: Glucocorticoid remains the treatment of choice in adult primary podocytopathy
(Minimal Change Disease, MCD and Focal Segmental Glomerulosclerosis, FSGS). The use …
(Minimal Change Disease, MCD and Focal Segmental Glomerulosclerosis, FSGS). The use …
Rituximab in maintaining remission in adults with podocytopathy
Rituximab is currently used after the conventional agents have failed in the management of
steroid‐dependent (SD)/steroid‐resistant (SR) podocytopathies and have a safer toxicity …
steroid‐dependent (SD)/steroid‐resistant (SR) podocytopathies and have a safer toxicity …
Minimal change disease: more than a podocytopathy?
RJ Maas, T Nijenhuis, J van der Vlag - Kidney International Reports, 2022 - kireports.org
Minimal change disease (MCD) is the main cause of the nephrotic syndrome in children and
accounts for 10% to 15% of adults presenting with the nephrotic syndrome. The term …
accounts for 10% to 15% of adults presenting with the nephrotic syndrome. The term …
Minimal change disease: Etiology, clinical features, and diagnosis in adults
A Meyrier, J Radhakrishnan… - & Fervenza, FC (Ed.) …, 2022 - uptodate.com
Minimal change disease (MCD) is a major cause of the nephrotic syndrome in children
(approximately 90 percent) and in a minority of adults (approximately 10 percent). MCD and …
(approximately 90 percent) and in a minority of adults (approximately 10 percent). MCD and …
Complement and podocytopathies: do we have a new biomarker?
M Blasco, AS Bomback - Kidney International Reports, 2024 - kireports.org
Minimal change disease (MCD) is defined by the absence of visible glomerular lesions on
light microscopy and effacement of foot processes on electron microscopy. MCD is the main …
light microscopy and effacement of foot processes on electron microscopy. MCD is the main …
Minimal change disease as a modifiable podocyte paracrine disorder
C Wei, J Reiser - Nephrology Dialysis Transplantation, 2011 - academic.oup.com
Nephrotic syndrome is a common illness dating back to the 15th century and known to affect
both children and adults [1]. There are three distinct histological variants of primary …
both children and adults [1]. There are three distinct histological variants of primary …
Minimal change disease
SB Bansal - Clinical queries: nephrology, 2014 - Elsevier
Minimal change disease is the commonest cause of nephrotic syndrome in children and
third most common cause in adults. There are new insights in the pathogenesis of disease …
third most common cause in adults. There are new insights in the pathogenesis of disease …